Academic lawyer/bioethicist studying pharmaceutical policy, access to investigational medicines, IRB quality (www.aereo.org), and clinical research ethics and regulation, with a splash of psychedelics.
Holly Fernandez Lynch
Loading...
And: "Researchers must be prepared to educate and engage their IRBs—and others in their institutions—about psychedelic risks, benefits, and appropriate protections as the field continues to develop, scientifically and ethically."
“My patient is refusing a drug studied in 170,000 people because of side effects that a 124,000-person analysis just confirmed do not exist — while injecting a compound studied in 14 humans, from unregulated sources, based on the recommendation of someone who profits from selling it.”
I asked Gemini a very simple question: "legitimate stem cell clinics"?
Response BRUTAL!
6/8 of the recommended clinics push unproven BS and 1 markets iffy procedures.
cc @stemcells.bsky.social @stemcellnetwork.ca
